Printer Friendly

Abstraits AUQ 2013.

Table

Table 1: Multivariate logistic regression [Table omitted]

Author Affiliation(s):

[1] Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, QC;

[2] Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany;

[3] Department of Urology, Ruhr University Bochum, Marienhospital, Herne, Germany;

[4] Department of Urology, Medical University of Vienna, Vienna, Austria;

[5] Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany;

[6] Department of Urology, Vita-Salute, San Raffaele University Milan, Italy;

[7] Department of Urology, University of Montreal Health Centre, Montreal, QC

[8] Department of Urology, Jewish General Hospital, McGill University, Montreal, QC

[9] McGill University Health Centre, Montreal, QC

[10] CHU de Quebec, CHUL, Quebec, QC

[11] McGill University Health Centre, Montreal, QC

[12] Universite de Montreal (CHUM), Henry Ford Health System, Montreal, QC

[13] Hopital St-Luc CHUM, Montreal, QC

[14] Division of Urology, McGill University, Montreal, QC

[15] Division of Urology, McGill University, Montreal, QC

[16] Montreal General Hospital and Division of Cancer Epidemiology - McGill University, Montreal, QC

[17] Montreal General Hospital, McGill University Health Centre, Montreal, QC

[18] Jewish General Hospital, Montreal, QC

[19] Henry Ford Health System, CHUM, Montreal, QC

[20] Jewish General Hospital, Montreal, QC

[21] Bladder Cancer Research Laboratory, Montreal General Hospital, Montreal, QC

[22] Centre Hospitalier de l'Universite de Montreal, Montreal, QC

[23] Centre Hospitalier de l'Universite de Montreal, Montreal, QC

[24] McGill University Health Centre, Montreal, QC

[25] CHUM et CRCHUM, Montreal, QC

[26] CHUQ-CHUL, Quebec, QC

[27] McGill University Health Centre, Montreal, QC

[28] Cancer Prognostics and Health Outcomes Unit, Centre Hospitalier de l'Universite de Montreal, Montreal, QC; Center for Outcomes Research and Analytics, Henry Ford Health System, Detroit, MI; CRCHUM, Centre Hospitalier de l'Universite de Montreal, Montreal, QC; Mayo Clinic, Department of Urology, Rochester, MN; Department of Urology, Georgetown University Hospital, Washington DC; Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

[29] Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Centre, Montreal, QC; Department of Urology, CHUM, Montreal, QC; Martini-Clinic, Prostate Cancer Center Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Ruhr University Bochum, Marienhospital, Herne, Germany; Department of Urology, Vita-Salute, San Raffaele University, Milan, Italy; Department of Urology, University-Hospital Hamburg-Eppendorf, Hamburg, Germany

[30] Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC

[31] Laboratoire d'Organogenese EXperimentale (LOEX) Hopital Enfant-Jesus, Quebec, QC

[32] CHU de Quebec/CRHDQ/Universite Laval, Quebec, QC

[33] CRCHUM, Centre Hospitalier de l'Universite de Montreal, Montreal, QC; Center for Outcomes Research and Analytics, Henry Ford Health System, Detroit, MI

[34] Western University, London, ON

[35] Centre Hospitalier Universitaire de Quebec (CHUQ), Universite Laval, Quebec, QC

[36] Universite Laval, Quebec, QC

[37] Centre hospitalier universitaire de Quebec, University Laval, Quebec, QC

[38] Indiana University School of Medicine, IN

[39] Indiana University School of Medicine, IN

[40] Departement de chirurgie, Service d'urologie, Universite Laval, Quebec, QC

[41] Urology Department, Jewish General Hospital, McGill University, Montreal, QC;

[42] Sherbrooke University, Sherbrooke, QC;

[43] Ottawa University, Ottawa, ON

[44] Urology Department, Jewish General Hospital, McGill University, Montreal, QC;

[45] Polystim Neurotechnologies Lab., Ecole Polytechnique de Montreal, Montreal, QC

[46] Centres hospitaliers des universites McGill, Montreal, Laval, Sherbrooke, et PROCURE Alliance, Montreal, QC

[47] Hopital General Juif, Universite McGill, Montreal, QC
COPYRIGHT 2013 Canadian Urological Association
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2013 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Abstraits AUQ 2013
Author:Trudeau, Vincent; Becker, Andreas; Roghmann, Florian; Shariat, Shahrokh F.; Kluth, Luis Alex; Hanna,
Publication:Canadian Urological Association Journal (CUAJ)
Date:Jul 1, 2013
Words:749
Previous Article:Flank bulge following supracostal percutaneous nephrolithotomy: a report of 2 cases.
Next Article:Updated assessment of neobladder utilization and morbidity according to urinary diversion after radical cystectomy: A contemporary...

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters